Early Intervention for Postpartum PTSD: Comparing Written Exposure and Capnometry-Guided Breathing Therapy
2 other identifiers
interventional
70
1 country
2
Brief Summary
The purpose of this study is to examine two early interventions, Written Exposure Therapy and Capnometry Guided Breathing, to reduce post-traumatic stress disorder (PTSD) symptoms in women after childbirth as compared to usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2026
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 9, 2026
CompletedFirst Posted
Study publicly available on registry
January 15, 2026
CompletedStudy Start
First participant enrolled
March 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
April 24, 2026
February 1, 2026
1.7 years
January 9, 2026
April 21, 2026
Conditions
Outcome Measures
Primary Outcomes (7)
Percentage of participants initiating assigned treatment
Proportion of participants who begin their assigned intervention (≥1 session for WET; completion of initial training for CGRI)
Baseline (up to 2 weeks)
Percentage of participants completing Written Exposure Therapy (WET)
Baseline to Week 6
Percentage adherence to Written Exposure Therapy (WET)
Baseline to Week 6
Percentage of participants completing Capnometry Guided Respiratory Intervention (CGRI)
Baseline to Week 6
Percentage adherence to Capnometry Guided Respiratory Intervention (CGRI)
Baseline to Week 6
Participant Satisfaction Scale Score using Client Satisfaction Questionnaire (CSQ-8)
Participant satisfaction measured using the CSQ-8 questionaire, an 8-item scale. (Scale score 8 - 32. Higher scores represent greater satisfaction with treatment.)
Week 5
Treatment credibility using the Opinion About Treatment (OAT) form
Participant perceptions of treatment credibility will be measured using the OAT form. (Scale score 3 - 27. Higher scores represent greater perceived credibility of the intervention.)
Week 5
Secondary Outcomes (15)
Change from baseline in PTSD Checklist for DSM-5 (PCL-5) Scale Score
Baseline, Week 1, Week 2, Week 3, Week 4, Week 5, Week 6, Week 12
Change from baseline in Edinburgh Postnatal Depression Scale (EPDS) Scale Score
Baseline, Week 1, Week 2, Week 3, Week 4, Week 5, Week 6, Week 12
Change from baseline in Whole Person Health Index (WPHI) Scale Score
Baseline, Week 3, Week 6, Week 12
Change from baseline in Generalized Anxiety Disorder Questionaire (GAD-7)
Baseline, Week 3, Week 6, Week 12
Change from baseline in Maternal-infant bonding (MIBS) Scale Score
Baseline, Week 3, Week 6, Week 12
- +10 more secondary outcomes
Study Arms (3)
Postpartum Standard of Care
NO INTERVENTIONParticipants will follow their current standard of care.
Written Exposure Therapy (WET)
EXPERIMENTALParticipants will complete 5 writing sessions. One 50-minute session will be held in the hospital before discharge, followed by four 50-minute sessions by secure video once a week. Sessions are delivered by a trained study therapist under licensed clinician supervision.
Capnometry-Guided Breathing Intervention (CGRI)
EXPERIMENTALParticipants will complete one 45-minute in-hospital training session using the device, which includes a tablet and breathing sensor. They will then practice guided breathing at home twice daily for about 17 minutes each time for 4 weeks, with weekly phone check-ins from study staff.
Interventions
Participants will complete 5 writing sessions. One 50-minute session will be held in the hospital before discharge, followed by four 50-minute sessions by secure video once a week. Sessions are delivered by a trained study therapist under licensed clinician supervision.
Participants will complete one 45-minute in-hospital training session using the device, which includes a tablet and breathing sensor. They will then practice guided breathing at home twice daily for about 17 minutes each time for 4 weeks, with weekly phone check-ins from study staff.
Eligibility Criteria
You may qualify if:
- Age ≥18
- Delivered a live infant within 5 days
- Severe maternal morbidity or infant admitted to NICU
- PCL-5 ≥28
- English-speaking
- Able to consent and participate
You may not qualify if:
- Active psychosis or mania
- Current suicidal crisis
- Current suicidal intent or plan
- Cognitive impairment preventing participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Center for Complementary and Integrative Health (NCCIH)collaborator
- Stanford Universitylead
- University of Arkansascollaborator
Study Sites (2)
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
Stanford University
Palo Alto, California, 94304, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pervez Sultan
Stanford University
- PRINCIPAL INVESTIGATOR
Debra Kaysen
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Anesthesiology, Perioperative and Pain Medicine (Obstetrics)
Study Record Dates
First Submitted
January 9, 2026
First Posted
January 15, 2026
Study Start
March 9, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
April 24, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Beginning 9 months and ending 36 months following article publication.
- Access Criteria
- Wish whom? Investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary") identified for this purpose. For what types of analysis? For individual participant data meta-analysis By what mechanism will data be made available? Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in our University's data warehouse but without investigator support other than deposited metadata. Information regarding submitting proposals and accessing data may be found at (Link to be provided).
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).